
Special Edition — Key Presentations from the 2023 American Society of Clinical Oncology (ASCO) Annual Meeting, Ovarian Cancer Issue
Oncology Today with Dr Neil Love
00:00
Niraprib and the Knee-Allegent
I think we look at when to start bev. If somebody comes in, big plural of fusions, the sitees, I'm going to give bev even in the knee-allegent. And for patients who are Braco wild type, HRD negative, would you ever consider adding niraprib to the bev? You know, we have some data that shows it safe. It is an option. The issue is the safety and hypertension need to make sure they're checking their blood pressure a couple of times a day,. particularly with nirap rib and the bev.
Transcript
Play full episode